Coronary angiographic findings do not predict clinical outcome in patients with unstable angina

F W Bär1, P Raynaud, J P Renkin

  • 1Center of the Unstable Angina Study Using Eminase (UNASEM) Group Academic Hospital Maastricht, University of Limburg, The Netherlands.

Insights

Thrombus formation and coronary artery lesion type did not predict clinical outcomes in unstable angina patients. This study found no correlation between these factors and changes in diameter stenosis or patient results.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Trials

Background:

  • Previous studies suggested thrombus formation and lesion type predict angiographic and clinical findings in unstable angina.
  • This retrospective analysis evaluated 159 patients from the Unstable Angina Study Using Eminase (UNASEM) trial.

Purpose of the Study:

  • To determine the presence and type of thrombus formation and coronary artery lesions in patients with unstable angina.
  • To correlate these findings with angiographic results and clinical outcomes.

Main Methods:

  • Included patients with unstable angina and ECG evidence of ischemia, excluding those with prior myocardial infarction.
  • Baseline and follow-up angiography were performed after administration of anistreplase or placebo.
  • 126 to 159 patients received study medication; 33 did not due to various reasons.

Main Results:

  • Anistreplase treatment significantly reduced diameter stenosis compared to placebo (11% vs. 3%, p=0.008).
  • No significant differences in clinical outcomes were observed between thrombolytic treatment and placebo (p=0.98).
  • Neither thrombus presence/absence nor lesion type correlated with diameter stenosis changes or clinical outcomes.

Conclusions:

  • In this cohort of unstable angina patients, coronary artery lesion type and thrombus formation do not predict clinical outcomes.
  • These findings suggest that focusing on lesion characteristics alone may not be sufficient for predicting patient prognosis in unstable angina.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...